Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial
暂无分享,去创建一个
A. Nagler | E. Shpall | Richard J. Jones | B. Andersson | S. Karandish | D. Couriel | A. Gee | R. Champlin | K. Komanduri | J. Mcmannis | T. Sadeghi | F. Grynspan | C. Hosing | I. Khouri | M. Lima | A Nagler | R. Jones | F Grynspan | E J Shpall | R Champlin | Y Daniely | M de Lima | J McMannis | A Gee | K Komanduri | D Couriel | B S Andersson | C Hosing | I Khouri | R Jones | S Karandish | T Sadeghi | T Peled | Y. Daniely | R. Champlin | T. Peled | D. Couriel
[1] E. Shpall,et al. Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies , 2006, Bone Marrow Transplantation.
[2] I. Millán,et al. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. , 2006, Haematologica.
[3] Arnon Nagler,et al. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. , 2005, Experimental hematology.
[4] K. Cornetta,et al. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] J. Wagner,et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.
[6] M. Labopin,et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.
[7] A. Nagler,et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. , 2004, Cytotherapy.
[8] A. Nagler,et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. , 2004, Experimental hematology.
[9] Pingfu Fu,et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. , 2003, Blood.
[10] J. Kurtzberg,et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. , 2003, Blood.
[11] E. Shpall,et al. Cord blood transplantation , 2002 .
[12] J Wagner,et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.
[13] Chan Zeng,et al. Transplantation of ex vivo expanded cord blood. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[14] A. Nagler,et al. Erratum: Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells (British Journal of Haematology 116:3 (655-661)) , 2002 .
[15] J. Wagner,et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.
[16] J. Wagner,et al. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. , 2001, The New England journal of medicine.
[17] P. Rubinstein,et al. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. , 2000, Bailliere's best practice & research. Clinical haematology.
[18] C. Chastang,et al. Outcome of cord-blood transplantation from related and unrelated donors , 1997 .
[19] C. Chastang,et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. , 1997, The New England journal of medicine.
[20] A. Deisseroth,et al. Tacrolimus and Minidose Methotrexate for Prevention of Acute Graft- Versus-Host Disease After Matched Unrelated Donor Marrow Transplantation , 1996 .
[21] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.